Go Deep
Anlon Healthcare Limited
Anlon Healthcare Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Sep 2026 | 20,658 | 50.2 | 8.00 | 0.17 | 34.66 |
| Sep 2026 | 20,658 | 50.2 | 8.00 | 0.17 | 34.66 |
| Sep 2026 | 20,658 | 50.2 | 8.00 | 0.17 | 34.66 |
| Oct 2026 | 20,242 | 47.6 | 7.59 | 0.17 | 32.86 |
| Oct 2026 | 20,790 | 41.3 | 6.49 | 0.17 | 28.11 |
Anlon Healthcare Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 875,627,000.0 | 508,891,000.0 | 355,780,000.0 | 522,013,000.0 |
| Net Profit | 66,621,000.0 | 104,976,000.0 | 51,520,000.0 | 93,173,000.0 |
| EPS | 0.2 | 0.2 | 0.1 | 0.2 |
Anlon Healthcare Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,719,656,000.0 | 1,202,866,000.0 | 665,837,000.0 | 1,128,774,000.0 | — |
| Net Profit | 285,138,000.0 | 205,179,000.0 | 96,571,000.0 | 58,200,000.0 | — |
| EPS | 0.6 | 0.4 | 0.2 | 0.1 | — |
Anlon Healthcare Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 3,739,651,000.0 | 1,813,000,000.0 | 1,280,008,000.0 | 1,115,479,000.0 | — |
| Total Liabilities | 1,191,709,000.0 | 1,008,783,000.0 | 1,069,694,000.0 | 1,041,737,000.0 | — |
| Total Equity | 2,302,286,000.0 | 804,217,000.0 | 210,314,000.0 | 73,742,000.0 | — |
Owes vs Owns
Anlon Healthcare Limited owed ₹0.32 for every ₹1 it owned in Mar 2026, down from ₹0.93 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.32× | 0.56× | 0.84× | 0.93× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Anlon Healthcare Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 1.2%Receivables 27.7%Inventory 30.3%Fixed assets (tangible) 12.5%Other assets 28.1%
How it's funded — Mar 2026
Short-term debt 10.0%Long-term debt 1.6%Payables 11.3%Other liabilities 8.9%Shareholders' equity 68.1%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 4.4 | 2.4 | 3.1 | 4.5 |
| Receivables | 103.7 | 75.0 | 38.7 | 43.8 |
| Inventory | 113.2 | 50.3 | 41.7 | 27.0 |
| Fixed assets (tangible) | 46.8 | 22.8 | 27.3 | 25.7 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 1.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 104.9 | 30.9 | 17.1 | 10.5 |
| Liabilities & equity | ||||
| Short-term debt | 37.6 | 28.2 | 27.0 | 12.1 |
| Long-term debt | 6.1 | 38.4 | 54.2 | 58.2 |
| Payables | 42.2 | 19.6 | 20.0 | 25.3 |
| Other liabilities | 33.3 | 14.7 | 5.7 | 8.5 |
| Shareholders' equity | 254.8 | 80.4 | 21.0 | 7.4 |
| Net tangible assets | 230.2 | 80.4 | 21.0 | 7.4 |
Anlon Healthcare Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | -794,400,000.0 | -225,518,000.0 | -32,260,000.0 | -28,497,000.0 | — |
| Investing Activities | -363,368,000.0 | 27,853,000.0 | -33,690,000.0 | -3,349,000.0 | — |
| Financing Activities | 1,186,931,000.0 | 189,416,000.0 | 82,458,000.0 | 22,659,000.0 | — |